![Frontiers | GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers Frontiers | GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers](https://www.frontiersin.org/files/Articles/411730/fonc-08-00490-HTML/image_m/fonc-08-00490-t001.jpg)
Frontiers | GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers
![Colors for Concrete | Pigments | Integral Color | Concrete Decor Store - Tagged "Pigments" Colors for Concrete | Pigments | Integral Color | Concrete Decor Store - Tagged "Pigments"](https://concretedecorstore.com/cdn/shop/products/6UGeMov3DB_300x_crop_top.jpg?v=1621645483)
Colors for Concrete | Pigments | Integral Color | Concrete Decor Store - Tagged "Pigments"
![Frontiers | GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers Frontiers | GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers](https://www.frontiersin.org/files/MyHome%20Article%20Library/411730/411730_Thumb_400.jpg)
Frontiers | GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers
![PDF) GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers PDF) GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers](https://www.researchgate.net/publication/328404073/figure/fig1/AS:11431281153928866@1682609001857/Distribution-and-occurrence-of-pathogenic-variants-along-BRCA1-A-and-BRCA2-B-in_Q320.jpg)
PDF) GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers
![Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers | Breast Cancer Research | Full Text Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr2785/MediaObjects/13058_2010_2764_Fig1_HTML.jpg)